A Multi-center, Randomized, Sham-controlled, Double-blind, Ascending-dose Study of SBI-101 Therapy in Subjects with Acute Kidney Injury Receiving Continuous Renal Replacement Therapy

August 17, 2018
https://clinicaltrials.gov/ct2/show/NCT03015623
Nephrology
Principal Investigator: Kausik Umanath, MD
Acute Kidney Injury, Continuous Renal Replacement Therapy
Accepting Participants